Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
15.04
+0.32 (2.17%)
Nov 22, 2024, 4:00 PM EST - Market closed
Assembly Biosciences Market Cap
Assembly Biosciences has a market cap or net worth of $95.60 million as of November 22, 2024. Its market cap has increased by 102.97% in one year.
Market Cap
95.60M
Enterprise Value
52.53K
1-Year Change
102.97%
Ranking
Category
Stock Price
$15.04
Market Cap Chart
Since December 17, 2010, Assembly Biosciences's market cap has increased from $40.20M to $95.60M, an increase of 137.81%. That is a compound annual growth rate of 6.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 95.50M | 77.18% |
| Dec 29, 2023 | 53.90M | -14.98% |
| Dec 30, 2022 | 63.40M | -43.14% |
| Dec 31, 2021 | 111.50M | -44.19% |
| Dec 31, 2020 | 199.80M | -62.51% |
| Dec 31, 2019 | 532.90M | -7.48% |
| Dec 31, 2018 | 576.00M | -26.83% |
| Dec 29, 2017 | 787.20M | 276.11% |
| Dec 30, 2016 | 209.30M | 61.75% |
| Dec 31, 2015 | 129.40M | 54.60% |
| Dec 31, 2014 | 83.70M | 5.02% |
| Dec 31, 2013 | 79.70M | 185.66% |
| Dec 31, 2012 | 27.90M | -71.93% |
| Dec 30, 2011 | 99.40M | 135.55% |
| Dec 31, 2010 | 42.20M | 4.98% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Leap Therapeutics | 97.57M |
| Tiziana Life Sciences | 97.57M |
| Adagene | 97.11M |
| Adlai Nortye | 97.05M |
| Regulus Therapeutics | 96.29M |
| Lineage Cell Therapeutics | 95.16M |
| Oramed Pharmaceuticals | 94.33M |
| Inotiv | 93.35M |